• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Reduced replication capacity of influenza A(H1N1)pdm09 virus during the 2010-2011 winter season in Tottori, Japan

tetano

Editor, Senior Moderator
J Med Virol. 2013 Nov;85(11):1871-7. doi: 10.1002/jmv.23700.
Reduced replication capacity of influenza A(H1N1)pdm09 virus during the 2010-2011 winter season in Tottori, Japan.
Tsuneki A, Itagaki A, Tsuchie H, Tokuhara M, Okada T, Narai S, Kasagi M, Tanaka K, Kageyama S.
Source

Division of Virology, Department of Microbiology and Immunology, Tottori University Faculty of Medicine, Yonago City, Japan; Tottori Infectious Diseases Forum, Tottori Prefecture, Japan.
Abstract

A novel swine-origin influenza A(H1N1)pdm09 virus has been circulating in humans since March-April, 2009. The 2009-2010 epidemic involved predominantly a single subtype of A(H1N1)pdm09 (at 96%, 46/48) in the sentinel sites of this study. However, A(H1N1)pdm09 started to circulate together with other type/subtype (49%, 33/68) at the first peak in the next epidemic season in 2010-2011: A(H1N1)pdm09/A(H3N2) (9%, 6/68), A(H1N1)pdm09/B (35%, 24/68), and A(H1N1)pdm09/A(H3N2)/B (4%, 3/68). Single infection of A(H1N1)pdm09 became a rare event (8%, 5/65) at the second peak of the same season in 2010-2011 compared with that at the first peak (50%, 34/68). Concurrently with this decline, single infections of others, A(H3N2) or B, became evident (6%, 4/65; 14%, 9/65, respectively). Triple infections were more common (29%, 19/65) at the second peak than at the first peak (4%). The A(H1N1)pdm09 detected in 2010-2011 produced less virus upon 72 hr of incubation in vitro after the inoculations at 10(4) and 3,300 copies/ml (2.3 ? 10(9) and 2.3 ? 10(9)  copies/ml on average) than that in 2009-2010 (3.7 ? 10(9) and 1.3 ? 10(10)  copies/ml on average; P < 0.05 by ANOVA test), respectively. As described above, the replication capacity of A(H1N1)pdm09 seems to have deteriorated in the 2010-2011 season presumably due to substantial herd immunity and allowed the existence of other type/subtype. These results suggest that assessment of replication capacity is indispensable for analysis of influenza epidemics. J Med. Virol. 85:1871-1877, 2013. ? 2013 Wiley Periodicals, Inc.

? 2013 Wiley Periodicals, Inc.
KEYWORDS:

A(H3N2), B, RNA levels, co-circulations, surveillance

PMID:
23983181
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23983181
 
Back
Top Bottom